Chengbo Yu

1.1k total citations
39 papers, 705 citations indexed

About

Chengbo Yu is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Chengbo Yu has authored 39 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 17 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Chengbo Yu's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis C virus research (8 papers). Chengbo Yu is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis B Virus Studies (9 papers) and Hepatitis C virus research (8 papers). Chengbo Yu collaborates with scholars based in China, Hong Kong and United States. Chengbo Yu's co-authors include Lanjuan Li, Shigui Yang, Min Deng, Bing Ruan, Jingjing Ren, Hongcui Cao, Ping Chen, Qing Cao, Kaijin Xu and Jun Yao and has published in prestigious journals such as PLoS ONE, Scientific Reports and The American Journal of Gastroenterology.

In The Last Decade

Chengbo Yu

37 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengbo Yu China 15 381 364 110 110 58 39 705
George Kessie Saudi Arabia 16 326 0.9× 259 0.7× 118 1.1× 118 1.1× 79 1.4× 31 686
Zheng Zeng China 14 452 1.2× 353 1.0× 105 1.0× 127 1.2× 84 1.4× 54 781
Vahdat Poortahmasebi Iran 15 208 0.5× 150 0.4× 21 0.2× 147 1.3× 111 1.9× 57 574
Bisma Rauff Pakistan 9 319 0.8× 326 0.9× 27 0.2× 83 0.8× 32 0.6× 21 670
Juandy Jo Indonesia 12 616 1.6× 530 1.5× 81 0.7× 252 2.3× 72 1.2× 33 1.3k
Samy Zaky Egypt 11 137 0.4× 126 0.3× 16 0.1× 125 1.1× 39 0.7× 42 564
Jun Sik Yoon South Korea 14 215 0.6× 144 0.4× 107 1.0× 273 2.5× 53 0.9× 42 764
María Luisa Manzano Spain 12 318 0.8× 296 0.8× 54 0.5× 23 0.2× 34 0.6× 43 548
Hongying Pan China 14 178 0.5× 92 0.3× 76 0.7× 160 1.5× 34 0.6× 49 552

Countries citing papers authored by Chengbo Yu

Since Specialization
Citations

This map shows the geographic impact of Chengbo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengbo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengbo Yu more than expected).

Fields of papers citing papers by Chengbo Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengbo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengbo Yu. The network helps show where Chengbo Yu may publish in the future.

Co-authorship network of co-authors of Chengbo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chengbo Yu. A scholar is included among the top collaborators of Chengbo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengbo Yu. Chengbo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xiaochen, et al.. (2025). Understanding and Treating Hepatorenal Syndrome: Insights from Recent Research. Seminars in Liver Disease. 45(3). 328–347.
2.
Zhang, Zhewei, et al.. (2024). Multi-Agent DRL-Based Resource Scheduling and Energy Management for Electric Vehicles. Electronics. 13(16). 3311–3311. 2 indexed citations
3.
Zhang, Xuan, Chengbo Yu, Li Xiao, et al.. (2024). IRE1α inhibits osteogenic differentiation of mouse embryonic fibroblasts by limiting Shh signaling. Oral Diseases. 30(7). 4504–4517. 1 indexed citations
4.
Yang, Sisi, et al.. (2022). Association between serum ferritin level and the various stages of non-alcoholic fatty liver disease: A systematic review. Frontiers in Medicine. 9. 934989–934989. 14 indexed citations
5.
Deng, Xiaoling, et al.. (2021). In vitro antibiofilm activity of resveratrol against avian pathogenic Escherichia coli. BMC Veterinary Research. 17(1). 249–249. 24 indexed citations
6.
Lü, Juan, et al.. (2021). Continuous elevation of procalcitonin in cirrhosis combined with hepatic carcinoma: a case report. BMC Infectious Diseases. 21(1). 29–29. 5 indexed citations
7.
Cao, Qing, Chengbo Yu, Shigui Yang, et al.. (2018). Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis. Hepatobiliary & pancreatic diseases international. 17(1). 9–16. 45 indexed citations
8.
Yang, Shigui, Cheng Ding, Yuanxia Cui, et al.. (2017). Prevalence and influencing factors of hepatitis B among a rural residential population in Zhejiang Province, China: a cross-sectional study. BMJ Open. 7(4). e014947–e014947. 18 indexed citations
9.
Huang, Jason L., Johnny Y. Jiang, Chengbo Yu, et al.. (2017). The Association between Distal Findings and Proximal Colorectal Neoplasia: A Systematic Review and Meta-Analysis. The American Journal of Gastroenterology. 112(8). 1234–1245. 8 indexed citations
10.
Chen, Ping, Qinfen Xie, Xuan Lü, et al.. (2017). Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA. Medicine. 96(33). e7766–e7766. 14 indexed citations
11.
Yu, Chengbo, Ping Chen, Shigui Yang, et al.. (2016). An updated dose–response meta-analysis of coffee consumption and liver cancer risk. Scientific Reports. 6(1). 37488–37488. 32 indexed citations
12.
Yang, Shigui, Dan Wang, Yuelun Zhang, et al.. (2015). Transmission of Hepatitis B and C Virus Infection Through Body Piercing. Medicine. 94(47). e1893–e1893. 33 indexed citations
13.
Yu, Chengbo. (2014). Evaluation of a novel choanoid fluidized bed bioreactor for future bioartificial livers. World Journal of Gastroenterology. 20(22). 6869–6869. 8 indexed citations
14.
Yu, Chengbo, Guoquan Lv, Hongcui Cao, et al.. (2014). Rapid Large-Scale Culturing of Microencapsulated Hepatocytes: A Promising Approach for Cell-Based Hepatic Support. Transplantation Proceedings. 46(5). 1649–1657. 7 indexed citations
15.
Yu, Chengbo, Jiajia Chen, Weibo Du, et al.. (2014). Effects of plasma exchange combined with continuous renal replacement therapy on acute fatty liver of pregnancy. Hepatobiliary & pancreatic diseases international. 13(2). 179–183. 24 indexed citations
16.
Chen, Ping, Chengbo Yu, Wei Wu, et al.. (2013). Serolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study. Hepatitis Monthly. 13(1). e7604–e7604. 11 indexed citations
17.
Chen, Ping, Chengbo Yu, Bing Ruan, et al.. (2013). Prevalence of Hepatitis B in Insular Regions of Southeast China: A Community-Based Study. PLoS ONE. 8(2). e56444–e56444. 32 indexed citations
18.
Yang, Shigui, Bing Wang, Ping Chen, et al.. (2012). Effectiveness of HBV Vaccination in Infants and Prediction of HBV Prevalence Trend under New Vaccination Plan: Findings of a Large-Scale Investigation. PLoS ONE. 7(10). e47808–e47808. 27 indexed citations
19.
Pan, Xiaoping, Weibo Du, Xiaopeng Yu, et al.. (2012). Establishment and characterization of immortalized human hepatocyte cell line for applications in bioartificial livers. Biotechnology Letters. 34(12). 2183–2190. 14 indexed citations
20.
Pan, Xiaoping, Weibo Du, Xiaopeng Yu, et al.. (2010). Establishment and Characterization of Immortalized Porcine Hepatocytes for the Study of Hepatocyte Xenotransplantation. Transplantation Proceedings. 42(5). 1899–1906. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026